Search research articles
Contact Us
Filters
Showing results (231-240 of 273) with videos related to
Page
of 28
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
February 21, 2016
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
David Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 19, 2020
Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting
Ki Hong Choi, Young Bin Song, Dong Seop Jeong, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases
|
January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>
Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 3, 2024
Clinical significance of residual ischaemia in acute myocardial infarction complicated by cardiogenic shock undergoing venoarterial-extracorporeal membrane oxygenation
David Hong, Ki Hong Choi, Chul-Min Ahn, et al.
British Journal of Cancer
|
September 4, 2021
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
Christian Rolfo, Alexander Drilon, David Hong, et al.
Journal of Translational Medicine
|
December 16, 2016
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors
Eileen Shi, Juliann Chmielecki, Chih-Min Tang, et al.
Science Translational Medicine
|
November 20, 2015
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
David Hong, Razelle Kurzrock, Youngsoo Kim, et al.
Journal of Medicinal Chemistry
|
March 18, 2017
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
W David Hong, Peter D Gibbons, Suet C Leung, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 273) with videos related to
Sort By:
Page
of 28
The Journal of Allergy and Clinical Immunology. in Practice
|
February 21, 2016
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
David Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 19, 2020
Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting
Ki Hong Choi, Young Bin Song, Dong Seop Jeong, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases
|
January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>
Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 3, 2024
Clinical significance of residual ischaemia in acute myocardial infarction complicated by cardiogenic shock undergoing venoarterial-extracorporeal membrane oxygenation
David Hong, Ki Hong Choi, Chul-Min Ahn, et al.
British Journal of Cancer
|
September 4, 2021
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
Christian Rolfo, Alexander Drilon, David Hong, et al.
Journal of Translational Medicine
|
December 16, 2016
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors
Eileen Shi, Juliann Chmielecki, Chih-Min Tang, et al.
Science Translational Medicine
|
November 20, 2015
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
David Hong, Razelle Kurzrock, Youngsoo Kim, et al.
Journal of Medicinal Chemistry
|
March 18, 2017
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
W David Hong, Peter D Gibbons, Suet C Leung, et al.
Page
of 28